PDL BioPharma (PDLI) revises its Q2 revenue guidance to ~$122M, down from prior guidance of...

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor

PDL BioPharma (PDLI) revises its Q2 revenue guidance to ~$122M, down from prior guidance of $128M, due to a mathematical error made on the earlier guidance. Shares -1.5%. (PR)